696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial

Bibliographic Details
Main Authors:	Choueiri, T.K., Powles, T., Burotto, M., Bourlon, M.T., Zurawski, B., Oyervides Juárez, Víctor Manuel, Hsieh, J.J., Basso, U., Shah, A.Y., Suarez, C., Hamzaj, A., Barrios, C.H., Richardet, M., Pook, D., Tomita, Y., Escudier, B., Zhang, J., Simsek, B., Apolo, A.B., Motzer, R.J.
Format:	Article
Language:	English
Published:	Kluwer university press 2020
Subjects:	RC Medicina Interna, Psiquiatría, Neurología
Online Access:	http://eprints.uanl.mx/22445/1/22445.pdf

Description
Description not available.

Similar Items